Profil
Samuil Umansky is the founder of Cardiff Oncology, Inc., which was founded in 1999.
He held the title of President from 1999 to 2006.
Currently, he is the President & Chief Scientific Officer at DiamiR LLC.
Aktive Positionen von Samuil Umansky
| Unternehmen | Position | Beginn |
|---|---|---|
DiamiR LLC
 DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Präsident | - |
Ehemalige bekannte Positionen von Samuil Umansky
| Unternehmen | Position | Ende |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DiamiR LLC
DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Health Technology |
